Skip to main content
Erschienen in: European Journal of Plastic Surgery 6/2020

17.08.2020 | Experimental Study

Effects of luteolin on random pattern skin flaps in rats

verfasst von: Mehmet Sönmez

Erschienen in: European Journal of Plastic Surgery | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Luteolin, a natural flavonoid, has anti-inflammatory, antioxidant, and antiapoptotic properties. Studies showed that luteolin protects tissues against ischemia-reperfusion injury on liver, neural tissue, and myocard. This study was designed to evaluate the effects of luteolin on random pattern skin flap in rats.

Methods

Sixteen rats were randomly divided into two groups (n = 8 each group: luteolin group: Land control group: C). Ten milligram per kilogram of luteolin diluted with saline was given intraperitoneally 30 min before and 12 h after surgery. Tissue samples were taken for biochemical analysis at the first day and at the seventh day for histopathological analysis. Catalase, malondialdehyde (MDA), xanthine oxidase (XO), and nitric oxide (NO) levels were measured with spectrophotometrical method. Edema, inflammatory cell infiltration, necrosis, and fibrosis were evaluated and scored. Flap survival ratios were measured. Statistical analysis was performed by SPSS for Windows 15.0.

Results

Tissue catalase levels were found significantly higher and MDA levels significantly lower in luteolin group respectively (L 65.38, C 39.80, p = 0.02; L 3.525, C 6.97, p = 0.01). XO and NO levels were found higher in luteolin group, but this difference was not significant (L 0.089, C 0.078, p = 0.17; L 41.75, C 37, p = 0.79). Edema, inflammatory cell infiltration, and necrosis were scored significantly lower in luteolin group (L +, C +++, p = 0.003; L +, C +++, p = 0.0004; L ±, C +++, p = 0.0021). Fibrosis scores were significantly higher in luteolin group (L +++, C +, p < 0.001). Flap survival was significantly higher in luteolin group (L 37.55, C 49.7, p = 0.02).

Conclusions

Luteolin has shown beneficial effects on random pattern skin flap in rats. Additional experiments are warranted to investigate the XO and NO mechanisms during ischemic injury.
Level of evidence: Not ratable
Literatur
1.
Zurück zum Zitat Akamatsu J, Ueda K, Tajima S, Nozawa M (2000) Sulfatide elongates dorsal skin flap survival in rats. J Surg Res 92:36–41PubMed Akamatsu J, Ueda K, Tajima S, Nozawa M (2000) Sulfatide elongates dorsal skin flap survival in rats. J Surg Res 92:36–41PubMed
2.
Zurück zum Zitat Loerakker S, Oomens CW, Manders E et al (2011) Ischemia-reperfusion injury in rat skeletal muscle assessed with T (2)-weighted and dynamic contrast-enhanced MRI. Magn Reson Med 66:528–537PubMed Loerakker S, Oomens CW, Manders E et al (2011) Ischemia-reperfusion injury in rat skeletal muscle assessed with T (2)-weighted and dynamic contrast-enhanced MRI. Magn Reson Med 66:528–537PubMed
3.
Zurück zum Zitat Shafighi M, Olariu R, Fathi AR, Djafarzadeh S, Jakob SM, Banic A, Constantinescu MA (2011) Dimethyloxalylglycine stabilizes HIF-1α in cultured human endothelial cells and increases random-pattern skin flap survival in vivo. Plast Reconstr Surg 128:415–422PubMed Shafighi M, Olariu R, Fathi AR, Djafarzadeh S, Jakob SM, Banic A, Constantinescu MA (2011) Dimethyloxalylglycine stabilizes HIF-1α in cultured human endothelial cells and increases random-pattern skin flap survival in vivo. Plast Reconstr Surg 128:415–422PubMed
4.
Zurück zum Zitat Park HJ, Lee S, Kang KH, Heo CY, Kim JH, Yang HS, Kim BS (2013) Enhanced random skin flap survival by sustained delivery of fibroblast growth factor 2 in rats. ANZ J Surg 83:354–358PubMed Park HJ, Lee S, Kang KH, Heo CY, Kim JH, Yang HS, Kim BS (2013) Enhanced random skin flap survival by sustained delivery of fibroblast growth factor 2 in rats. ANZ J Surg 83:354–358PubMed
5.
Zurück zum Zitat Gideroglu K, Yilmaz F, Aksoy F, Bugdayci G, Saglam I, Yimaz F (2009) Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury. J Surg Res 157:181–186PubMed Gideroglu K, Yilmaz F, Aksoy F, Bugdayci G, Saglam I, Yimaz F (2009) Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury. J Surg Res 157:181–186PubMed
6.
Zurück zum Zitat Rinker B, Fink BF, Barry NG, Fife JA, Milan ME (2010) The effect of calcium channel blockers on smoking-induced skin flap necrosis. Plast Reconstr Surg 125:866–871PubMed Rinker B, Fink BF, Barry NG, Fife JA, Milan ME (2010) The effect of calcium channel blockers on smoking-induced skin flap necrosis. Plast Reconstr Surg 125:866–871PubMed
7.
Zurück zum Zitat Freitas FA, Piccinato CE, Cherri J, Marchesan WG (2010) Effects of pentoxyfilline and heparin on reperfusion injury island skin flaps in rats exposed to tobacco. J Surg Res 164:139–145PubMed Freitas FA, Piccinato CE, Cherri J, Marchesan WG (2010) Effects of pentoxyfilline and heparin on reperfusion injury island skin flaps in rats exposed to tobacco. J Surg Res 164:139–145PubMed
8.
Zurück zum Zitat Kwon ST, Jeong JH, Eun SC, Baek RM et al (2009) The effects of mega-dose ascorbic acid on skin flap survival: experimental study on rats. J Plast Reconstr Aesthet Surg 62:641–642 Kwon ST, Jeong JH, Eun SC, Baek RM et al (2009) The effects of mega-dose ascorbic acid on skin flap survival: experimental study on rats. J Plast Reconstr Aesthet Surg 62:641–642
9.
Zurück zum Zitat Ziyan L, Yongmei Z, Nan Z, Ning T, Baolin L (2007) Evaluation of the anti-inflammatory activity of luteolin in experimental animal models. Planta Med 73:221–226PubMed Ziyan L, Yongmei Z, Nan Z, Ning T, Baolin L (2007) Evaluation of the anti-inflammatory activity of luteolin in experimental animal models. Planta Med 73:221–226PubMed
10.
Zurück zum Zitat Hu C, Kitts DD (2004) Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem 265:107–113PubMed Hu C, Kitts DD (2004) Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem 265:107–113PubMed
11.
Zurück zum Zitat López-Lázaro M (2009) Distribution and biological activities of luteolin. Mini Rev Med Chem 9:31–59PubMed López-Lázaro M (2009) Distribution and biological activities of luteolin. Mini Rev Med Chem 9:31–59PubMed
12.
Zurück zum Zitat Kim JS, Jobin C (2005) The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 115:375–387PubMedPubMedCentral Kim JS, Jobin C (2005) The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 115:375–387PubMedPubMedCentral
13.
Zurück zum Zitat Choi BM, Lim DW, Lee JA, Gao SS, Kwon DY, Kim BR (2008) Luteolin suppresses cisplatin-induced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression. J Med Food 11:230–236PubMed Choi BM, Lim DW, Lee JA, Gao SS, Kwon DY, Kim BR (2008) Luteolin suppresses cisplatin-induced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression. J Med Food 11:230–236PubMed
14.
Zurück zum Zitat Fang F, Li D, Pan H, Chen D, Qi L, Zhang R, Sun H (2011) Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion. Pharmacology 88:149–158PubMed Fang F, Li D, Pan H, Chen D, Qi L, Zhang R, Sun H (2011) Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion. Pharmacology 88:149–158PubMed
15.
Zurück zum Zitat Zhu LH, Bi W, Qi RB, Wang HD, Lu DX (2011) Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. Int J Neurosci 121:329–336PubMed Zhu LH, Bi W, Qi RB, Wang HD, Lu DX (2011) Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. Int J Neurosci 121:329–336PubMed
16.
Zurück zum Zitat Wang GG, Lu XH, Ding M, Tang WT, Li W, Zhao X, Zhang C (2011) Protective effects of luteolin preconditioning on rat liver under ischemia/reperfusion. Sheng Li Xue Bao 63:177–183PubMed Wang GG, Lu XH, Ding M, Tang WT, Li W, Zhao X, Zhang C (2011) Protective effects of luteolin preconditioning on rat liver under ischemia/reperfusion. Sheng Li Xue Bao 63:177–183PubMed
17.
Zurück zum Zitat Moon JG, Lim HC, Gye MR, Oh JS, Park JW (2008) Postconditioning attenuates ischaemia-reperfusion injury in rat skin flap. Microsurgery 28:531–537PubMed Moon JG, Lim HC, Gye MR, Oh JS, Park JW (2008) Postconditioning attenuates ischaemia-reperfusion injury in rat skin flap. Microsurgery 28:531–537PubMed
18.
Zurück zum Zitat Dahle LK, Hill EG, Hollman RT (1962) The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arc Biochem Biophys 98:253–261 Dahle LK, Hill EG, Hollman RT (1962) The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arc Biochem Biophys 98:253–261
19.
Zurück zum Zitat Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126 Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126
20.
Zurück zum Zitat Ridnour LA, Sim JE, Hayward MA, Wink DA, Martin SM, Buettner GR, Spitz DR (2000) A spectrophotometric method for the direct detection and quantitation of nitric oxide, nitrite, and nitrate in cell culture media. Anal Biochem 281:223–229PubMed Ridnour LA, Sim JE, Hayward MA, Wink DA, Martin SM, Buettner GR, Spitz DR (2000) A spectrophotometric method for the direct detection and quantitation of nitric oxide, nitrite, and nitrate in cell culture media. Anal Biochem 281:223–229PubMed
21.
Zurück zum Zitat Corrocher R, Carasil M, Bellisola G (1986) Severe impairment of antioxidant system in human hepatoma. Cancer 58:1658–1662PubMed Corrocher R, Carasil M, Bellisola G (1986) Severe impairment of antioxidant system in human hepatoma. Cancer 58:1658–1662PubMed
22.
Zurück zum Zitat Karaaslan O, Ulusoy MG, Kankaya Y, Tiftikcioglu YO, Kocer U, Kankaya D, Karaaslan GM, Tuncer S, Berktas M (2010) Protective effect of grape seed extract against ischaemia – reperfusion injury in a rat epigastric flap model. J Plast Reconstr Aesthet Surg 63:705–710PubMed Karaaslan O, Ulusoy MG, Kankaya Y, Tiftikcioglu YO, Kocer U, Kankaya D, Karaaslan GM, Tuncer S, Berktas M (2010) Protective effect of grape seed extract against ischaemia – reperfusion injury in a rat epigastric flap model. J Plast Reconstr Aesthet Surg 63:705–710PubMed
23.
Zurück zum Zitat Suzuki S, Miyachi Y, Niwa Y, Isshiki N (1989) Significance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD. Br J Plast Surg 42:559–564PubMed Suzuki S, Miyachi Y, Niwa Y, Isshiki N (1989) Significance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD. Br J Plast Surg 42:559–564PubMed
24.
Zurück zum Zitat Aydogan H, Gurlek A, Parlakpinar H, Askar I, Bay-Karabulut A, Aydogan N, Fariz A, Acet A (2007) Beneficial effects of caffeic acid phenethyl ester (CAPE) on the ischaemia-reperfusion injury in rat skin flaps. J Plast Recons Aesth Surg 60:563–568 Aydogan H, Gurlek A, Parlakpinar H, Askar I, Bay-Karabulut A, Aydogan N, Fariz A, Acet A (2007) Beneficial effects of caffeic acid phenethyl ester (CAPE) on the ischaemia-reperfusion injury in rat skin flaps. J Plast Recons Aesth Surg 60:563–568
25.
Zurück zum Zitat Rice-Evans CA, Miller NJ, Paganga G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933–956PubMed Rice-Evans CA, Miller NJ, Paganga G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933–956PubMed
26.
Zurück zum Zitat Mira L, Fernandez MT, Santos M, Rocha R et al (2002) Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36:1199–1208PubMed Mira L, Fernandez MT, Santos M, Rocha R et al (2002) Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36:1199–1208PubMed
27.
Zurück zum Zitat De Martino L, Mencherini T, Mancini E, Aquino RP et al (2012) In vitro phytotoxicity and antioxidant activity of selected flavonoids. Int J Mol Sci 13:5406–5419PubMedPubMedCentral De Martino L, Mencherini T, Mancini E, Aquino RP et al (2012) In vitro phytotoxicity and antioxidant activity of selected flavonoids. Int J Mol Sci 13:5406–5419PubMedPubMedCentral
28.
Zurück zum Zitat Seelinger G, Merfort I, Schempp CM (2008) Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74:1667–1677PubMed Seelinger G, Merfort I, Schempp CM (2008) Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74:1667–1677PubMed
29.
Zurück zum Zitat Fang L, Zhang M, Ding Y, Fang Y et al (2010) Protective effects of luteolin on neurons against oxygen-glucose deprivation/reperfusion injury via improving Na+/K+ -ATPase activity. Zhongguo Zhong Yao Za Zhi 35:1051–1054PubMed Fang L, Zhang M, Ding Y, Fang Y et al (2010) Protective effects of luteolin on neurons against oxygen-glucose deprivation/reperfusion injury via improving Na+/K+ -ATPase activity. Zhongguo Zhong Yao Za Zhi 35:1051–1054PubMed
30.
Zurück zum Zitat Liao PH, Hung LM, Chen YH, Kuan YH, Zhang FBY, Lin RH, Shih HC, Tsai SK, Huang SS (2011) Cardioprotective effects of luteolin during ischemia-reperfusion injury in rats. Circ J 75:443–450PubMed Liao PH, Hung LM, Chen YH, Kuan YH, Zhang FBY, Lin RH, Shih HC, Tsai SK, Huang SS (2011) Cardioprotective effects of luteolin during ischemia-reperfusion injury in rats. Circ J 75:443–450PubMed
31.
Zurück zum Zitat Theoharides TC, Asadi S, Panagiotidou S (2012) A case series of a luteolin formulation (NeuroProtek®) in children with autism spectrum disorders. Int J Immunopathol Pharmacol 25:317–323PubMed Theoharides TC, Asadi S, Panagiotidou S (2012) A case series of a luteolin formulation (NeuroProtek®) in children with autism spectrum disorders. Int J Immunopathol Pharmacol 25:317–323PubMed
32.
Zurück zum Zitat Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, Hara Y, Yamamoto H, Kinae N (1998) Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 438:220–224PubMed Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, Hara Y, Yamamoto H, Kinae N (1998) Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 438:220–224PubMed
33.
Zurück zum Zitat Chen X, Liu L, Sun Z, Liu Y, Xu J, Liu S, Huang B, Ma L, Yu Z, Bi K (2010) Pharmacokinetics of luteolin and tetra-acetyl-luteolin assayed by HPLC in rats after oral administration. Biomed Chromatogr 24:826–832PubMed Chen X, Liu L, Sun Z, Liu Y, Xu J, Liu S, Huang B, Ma L, Yu Z, Bi K (2010) Pharmacokinetics of luteolin and tetra-acetyl-luteolin assayed by HPLC in rats after oral administration. Biomed Chromatogr 24:826–832PubMed
34.
Zurück zum Zitat Tsai FS, Peng WH, Wang WH, Wu CR, Hsieh CC, Lin YT, Feng IC, Hsieh MT (2007) Effects of luteolin on learning acquisition in rats: involvement of the central cholinergic system. Life Sci 80:1692–1698PubMed Tsai FS, Peng WH, Wang WH, Wu CR, Hsieh CC, Lin YT, Feng IC, Hsieh MT (2007) Effects of luteolin on learning acquisition in rats: involvement of the central cholinergic system. Life Sci 80:1692–1698PubMed
35.
Zurück zum Zitat Papaliodis D, Boucher W, Kempuraj D, Theoharides TC (2008) The flavonoid luteolin inhibits niacin-induced flush. Br J Pharmacol 153:1382–1387PubMedPubMedCentral Papaliodis D, Boucher W, Kempuraj D, Theoharides TC (2008) The flavonoid luteolin inhibits niacin-induced flush. Br J Pharmacol 153:1382–1387PubMedPubMedCentral
36.
Zurück zum Zitat Cordeiro PG, Lee JJ, Mastorakos D, Hu QY, Pinto JT, Santamaria E (2000) Prevention of ischemia-reperfusion injury in a rat skin flap model: the role of mast cells, cromolyn sodium, and histamine receptor blockade. Plast Reconstr Surg 105:654–659PubMed Cordeiro PG, Lee JJ, Mastorakos D, Hu QY, Pinto JT, Santamaria E (2000) Prevention of ischemia-reperfusion injury in a rat skin flap model: the role of mast cells, cromolyn sodium, and histamine receptor blockade. Plast Reconstr Surg 105:654–659PubMed
37.
Zurück zum Zitat Chen G, Shen H, Zang L, Su Z, Huang J, Sun Y, Wang H (2018 Dec) Protective effect of luteolin on skin ischemia-reperfusion injury through an AKT-dependent mechanism. Int J Mol Med 42:3073–3082PubMedPubMedCentral Chen G, Shen H, Zang L, Su Z, Huang J, Sun Y, Wang H (2018 Dec) Protective effect of luteolin on skin ischemia-reperfusion injury through an AKT-dependent mechanism. Int J Mol Med 42:3073–3082PubMedPubMedCentral
38.
Zurück zum Zitat Qiao H, Dong L, Zhang X, Zhu C, Zhang X, Wang L, Liu Z, Chen L, Xing Y, Wang C, Li Y (2012) Protective effect of luteolin in experimental ischaemic stroke: upregulated SOD1, CAT, Bcl-2 and claudin-5, down-regulated MDA and Bax expression. Neurochem Res 37:2014–2024PubMed Qiao H, Dong L, Zhang X, Zhu C, Zhang X, Wang L, Liu Z, Chen L, Xing Y, Wang C, Li Y (2012) Protective effect of luteolin in experimental ischaemic stroke: upregulated SOD1, CAT, Bcl-2 and claudin-5, down-regulated MDA and Bax expression. Neurochem Res 37:2014–2024PubMed
39.
Zurück zum Zitat Taleb S, Moghaddas P, Rahimi Balaei M, Taleb S, Rahimpour S, Abbasi A, Ejtemaei-Mehr S, Dehpour AR (2014) Metformin improves skin flap survival through nitric oxide system. J Surg Res 192:686–691PubMed Taleb S, Moghaddas P, Rahimi Balaei M, Taleb S, Rahimpour S, Abbasi A, Ejtemaei-Mehr S, Dehpour AR (2014) Metformin improves skin flap survival through nitric oxide system. J Surg Res 192:686–691PubMed
40.
Zurück zum Zitat Wu MY, Yiang GT, Liao WT, Tsai AP et al (2018) Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem 46:1650–1667PubMed Wu MY, Yiang GT, Liao WT, Tsai AP et al (2018) Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem 46:1650–1667PubMed
41.
Zurück zum Zitat Chen CY, Peng WH, Wu LC, Wu CC, Hsu SL (2010) Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: implications for therapy of lung fibrosis. J Agric Food Chem 58:11653–11661 Chen CY, Peng WH, Wu LC, Wu CC, Hsu SL (2010) Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: implications for therapy of lung fibrosis. J Agric Food Chem 58:11653–11661
42.
Zurück zum Zitat Domitrović R, Jakovac H, Tomac J, Sain I (2009) Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol Appl Pharmacol 241:311–321PubMed Domitrović R, Jakovac H, Tomac J, Sain I (2009) Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol Appl Pharmacol 241:311–321PubMed
Metadaten
Titel
Effects of luteolin on random pattern skin flaps in rats
verfasst von
Mehmet Sönmez
Publikationsdatum
17.08.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Plastic Surgery / Ausgabe 6/2020
Print ISSN: 0930-343X
Elektronische ISSN: 1435-0130
DOI
https://doi.org/10.1007/s00238-020-01719-8

Weitere Artikel der Ausgabe 6/2020

European Journal of Plastic Surgery 6/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.